NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|193788461|dbj|BAG53355|]
View 

unnamed protein product [Homo sapiens]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats; similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-405 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 665.05  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   1 MNCADIDIITASYAPEGDEEIHATGFNYQNEDEKVTLSFPSTLQTG-TGTLKIDFVGELNDKMKGFYRSKYTTPSGEVRY 79
Cdd:cd09601   35 LHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPGeNYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRY 114
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  80 AAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALSNMNVIDRKPYPDDenLVEVKFARTPVMSTYLVAFVVGEY 159
Cdd:cd09601  115 LAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPVESTELEDG--WKTTTFETTPPMSTYLVAFVVGDF 192
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 160 DFVETRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLI 239
Cdd:cd09601  193 EYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLY 272
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 240 DPKNSCSSSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDAL 319
Cdd:cd09601  273 DPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSL 352
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 320 DNSHPIEVSVGHPSEVDEIFDAISYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGR----P 395
Cdd:cd09601  353 ASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGEskplD 432
                        410
                 ....*....|
gi 193788461 396 IAAVMNTWTK 405
Cdd:cd09601  433 VKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
484-756 3.19e-89

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 283.01  E-value: 3.19e-89
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  484 WVKLNLGTVGFYRTQYSSAMLESLLPGIRDLSLPPVDRLGLQNDLFSLSRAGIISTVEVLKVMEAFVNEPNYTVWSDLSC 563
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  564 NLGILSTLLSHTDFYEEIQEFVKDVFSPIGERLGWDPKPGEGHLDALLRGLVLGKLGKAGHKATLEEAHRRFKDHVEGKQ 643
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  644 ILSADLRSPVYLTVLKHGDGTTLDIMLKLHKQADMQEEKNRIERVLGATLLPDLIQKVLTFAL-SEEVRPQDTVSVIGGV 722
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270
                  ....*....|....*....|....*....|....
gi 193788461  723 AGgSKHGRKAAWKFIKDNWEELYNRYQGGFLISY 756
Cdd:pfam11838 241 AS-NPAGRDLAWDFVKENWDALVKRLGGGSSLGR 273
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-405 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 665.05  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   1 MNCADIDIITASYAPEGDEEIHATGFNYQNEDEKVTLSFPSTLQTG-TGTLKIDFVGELNDKMKGFYRSKYTTPSGEVRY 79
Cdd:cd09601   35 LHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPGeNYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRY 114
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  80 AAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALSNMNVIDRKPYPDDenLVEVKFARTPVMSTYLVAFVVGEY 159
Cdd:cd09601  115 LAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPVESTELEDG--WKTTTFETTPPMSTYLVAFVVGDF 192
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 160 DFVETRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLI 239
Cdd:cd09601  193 EYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLY 272
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 240 DPKNSCSSSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDAL 319
Cdd:cd09601  273 DPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSL 352
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 320 DNSHPIEVSVGHPSEVDEIFDAISYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGR----P 395
Cdd:cd09601  353 ASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGEskplD 432
                        410
                 ....*....|
gi 193788461 396 IAAVMNTWTK 405
Cdd:cd09601  433 VKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
27-566 8.77e-138

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 419.43  E-value: 8.77e-138
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  27 NYQNEDEKVTLSFPSTLQTG-TGTLKIDFVGELNDKMKGFYRSKYTtpsGEVRYAAVTQFEATDARRAFPCWDEPAIKAT 105
Cdd:COG0308   71 DFTRDGERLTITLPKPLAPGeTFTLEIEYSGKPSNGGEGLYRSGDP---PDGPPYLYTQCEPEGARRWFPCFDHPDDKAT 147
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 106 FDISLVVPKDRVALSNMNVIDRKPYPDdeNLVEVKFARTPVMSTYLVAFVVGEYDFVETRSKDGVCVRVYTPVGKAEQGK 185
Cdd:COG0308  148 FTLTVTVPAGWVAVSNGNLVSETELGD--GRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAK 225
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 186 FALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETalLIDPKNSCSSSRQWVALVVGHELAHQWF 265
Cdd:COG0308  226 EAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK--VLADETATDADYERRESVIAHELAHQWF 303
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 266 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEyDIWTQFVSADYTRAQ-ELDALDNSHPIEVSvgHPSEVDEIFDAISY 344
Cdd:COG0308  304 GNLVTCADWDDLWLNEGFATYMEQLFSEDLYGK-DAADRIFVGALRSYAfAEDAGPNAHPIRPD--DYPEIENFFDGIVY 380
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 345 SKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTWTKQMGFPLIYVEAEQVEDDRL 424
Cdd:COG0308  381 EKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKV 460
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 425 -LRLSQKKFcaggsyvgeDCPQWMVPITISTsEDPNQAKLKILMDKPEMNVVlknVKPDqWVKLNLgtvgfyrtqyssam 503
Cdd:COG0308  461 tLTLRQTPP---------RPHPFHIPLEVGL-LGGKLTARTVLLDGEQTELV---AKPD-PVLLLR-------------- 512
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 193788461 504 LESLLPGIRDLSLPPVDRLGLQNDLFSLSRAGIISTVEVLKvmeafvnEPNYTVWSDLSCNLG 566
Cdd:COG0308  513 LDDELAFLLAHDSDPFNRWEALQALWRDGEADYLDALRALA-------DTDPAVRAEALALLG 568
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
186-403 1.07e-123

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 368.54  E-value: 1.07e-123
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  186 FALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCSSSRQWVALVVGHELAHQWF 265
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  266 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYS 345
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 193788461  346 KGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGR-PIAAVMNTW 403
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGPlDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
484-756 3.19e-89

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 283.01  E-value: 3.19e-89
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  484 WVKLNLGTVGFYRTQYSSAMLESLLPGIRDLSLPPVDRLGLQNDLFSLSRAGIISTVEVLKVMEAFVNEPNYTVWSDLSC 563
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  564 NLGILSTLLSHTDFYEEIQEFVKDVFSPIGERLGWDPKPGEGHLDALLRGLVLGKLGKAGHKATLEEAHRRFKDHVEGKQ 643
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  644 ILSADLRSPVYLTVLKHGDGTTLDIMLKLHKQADMQEEKNRIERVLGATLLPDLIQKVLTFAL-SEEVRPQDTVSVIGGV 722
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270
                  ....*....|....*....|....*....|....
gi 193788461  723 AGgSKHGRKAAWKFIKDNWEELYNRYQGGFLISY 756
Cdd:pfam11838 241 AS-NPAGRDLAWDFVKENWDALVKRLGGGSSLGR 273
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
42-424 5.89e-81

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 275.90  E-value: 5.89e-81
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   42 TLQTGTGTLKIDFVGELNDKMKGFYRskYTTPS-GEVrYAaVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALS 120
Cdd:TIGR02412  84 GLLTGENTLRVEATRAYTNTGEGLHR--FVDPVdGEV-YL-YTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVIS 159
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  121 NMNVIDRKPYPDDENLvevKFARTPVMSTYLVAFVVGEYDFVETRSkDGVCVRVYTPVGKAEQ--GKFALEVAAKTLPFY 198
Cdd:TIGR02412 160 NSRETDVTPEPADRRW---EFPETPKLSTYLTAVAAGPYHSVQDES-RSYPLGIYARRSLAQYldADAIFTITRQGLAFF 235
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  199 KDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNScsSSRQWVALVVGHELAHQWFGNLVTMEWWTHLW 278
Cdd:TIGR02412 236 HRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEATR--AEKENRAGVILHEMAHMWFGDLVTMRWWNDLW 313
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  279 LNEGFASWIEYLCVDHCfPEY-DIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYSKGASVIRMLHDY 357
Cdd:TIGR02412 314 LNESFAEYMGTLASAEA-TEYtDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAW 392
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 193788461  358 IGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTWTKQMGFPLIYVEAEqVEDDRL 424
Cdd:TIGR02412 393 VGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEIT-TDGGVV 458
pepN PRK14015
aminopeptidase N; Provisional
64-434 2.67e-20

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 96.35  E-value: 2.67e-20
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  64 GFYRSkyttpSGevryAAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDR--VALSNMNVIDRKPYPDDEnlvevKF 141
Cdd:PRK14015 113 GLYRS-----GG----MFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKypVLLSNGNLVESGELPDGR-----HW 178
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 142 AR----TPVMStYLVAFVVGEYDFVE----TRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNVPYplpkiDL 213
Cdd:PRK14015 179 ATwedpFPKPS-YLFALVAGDLDVLEdtftTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY-----DL 252
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 214 -----IAIADFAAGAMENWGLVTYRETALLIDPKNSCSSSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGfaswie 288
Cdd:PRK14015 253 difmiVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEG------ 326
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 289 yLCV--DHCFpeydiwtqfvSAD-------------YTRAQEL--DALDNSHPIEvsvghPSEVDEI---FDAISYSKGA 348
Cdd:PRK14015 327 -LTVfrDQEF----------SADlgsravkriedvrVLRAAQFaeDAGPMAHPVR-----PDSYIEInnfYTATVYEKGA 390
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 349 SVIRMLHDYIGDKDFKKGMNMYLTKF--QqknAAT-EDLWESLENASGRPIAAVMNtWTKQMGFPLIYVEAEQVEDDRLL 425
Cdd:PRK14015 391 EVIRMLHTLLGEEGFRKGMDLYFERHdgQ---AVTcEDFVAAMEDASGRDLSQFRR-WYSQAGTPRVTVSDEYDAAAGTY 466

                 ....*....
gi 193788461 426 RLSQKKFCA 434
Cdd:PRK14015 467 TLTLSQSTP 475
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-405 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 665.05  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   1 MNCADIDIITASYAPEGDEEIHATGFNYQNEDEKVTLSFPSTLQTG-TGTLKIDFVGELNDKMKGFYRSKYTTPSGEVRY 79
Cdd:cd09601   35 LHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPGeNYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRY 114
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  80 AAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALSNMNVIDRKPYPDDenLVEVKFARTPVMSTYLVAFVVGEY 159
Cdd:cd09601  115 LAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPVESTELEDG--WKTTTFETTPPMSTYLVAFVVGDF 192
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 160 DFVETRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLI 239
Cdd:cd09601  193 EYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLY 272
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 240 DPKNSCSSSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDAL 319
Cdd:cd09601  273 DPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSL 352
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 320 DNSHPIEVSVGHPSEVDEIFDAISYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGR----P 395
Cdd:cd09601  353 ASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGEskplD 432
                        410
                 ....*....|
gi 193788461 396 IAAVMNTWTK 405
Cdd:cd09601  433 VKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
27-566 8.77e-138

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 419.43  E-value: 8.77e-138
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  27 NYQNEDEKVTLSFPSTLQTG-TGTLKIDFVGELNDKMKGFYRSKYTtpsGEVRYAAVTQFEATDARRAFPCWDEPAIKAT 105
Cdd:COG0308   71 DFTRDGERLTITLPKPLAPGeTFTLEIEYSGKPSNGGEGLYRSGDP---PDGPPYLYTQCEPEGARRWFPCFDHPDDKAT 147
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 106 FDISLVVPKDRVALSNMNVIDRKPYPDdeNLVEVKFARTPVMSTYLVAFVVGEYDFVETRSKDGVCVRVYTPVGKAEQGK 185
Cdd:COG0308  148 FTLTVTVPAGWVAVSNGNLVSETELGD--GRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAK 225
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 186 FALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETalLIDPKNSCSSSRQWVALVVGHELAHQWF 265
Cdd:COG0308  226 EAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK--VLADETATDADYERRESVIAHELAHQWF 303
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 266 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEyDIWTQFVSADYTRAQ-ELDALDNSHPIEVSvgHPSEVDEIFDAISY 344
Cdd:COG0308  304 GNLVTCADWDDLWLNEGFATYMEQLFSEDLYGK-DAADRIFVGALRSYAfAEDAGPNAHPIRPD--DYPEIENFFDGIVY 380
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 345 SKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTWTKQMGFPLIYVEAEQVEDDRL 424
Cdd:COG0308  381 EKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKV 460
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 425 -LRLSQKKFcaggsyvgeDCPQWMVPITISTsEDPNQAKLKILMDKPEMNVVlknVKPDqWVKLNLgtvgfyrtqyssam 503
Cdd:COG0308  461 tLTLRQTPP---------RPHPFHIPLEVGL-LGGKLTARTVLLDGEQTELV---AKPD-PVLLLR-------------- 512
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 193788461 504 LESLLPGIRDLSLPPVDRLGLQNDLFSLSRAGIISTVEVLKvmeafvnEPNYTVWSDLSCNLG 566
Cdd:COG0308  513 LDDELAFLLAHDSDPFNRWEALQALWRDGEADYLDALRALA-------DTDPAVRAEALALLG 568
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
186-403 1.07e-123

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 368.54  E-value: 1.07e-123
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  186 FALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCSSSRQWVALVVGHELAHQWF 265
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  266 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYS 345
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 193788461  346 KGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGR-PIAAVMNTW 403
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGPlDVDSFMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
31-406 1.48e-107

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 335.25  E-value: 1.48e-107
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  31 EDEKVTLsfPSTLQTGTGTLKIDFVGELNDKMKGFYRskYTTPSGEVRYAaVTQFEATDARRAFPCWDEPAIKATFDISL 110
Cdd:cd09602   73 DGERITL--PGLLKAGENTVVVEFTAPYSSDGEGLHR--FVDPADGETYL-YTLFEPDDARRVFPCFDQPDLKATFTLTV 147
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 111 VVPKDRVALSNMNVIDRkpyPDDENLVEVKFARTPVMSTYLVAFVVGEYDFVEtRSKDGVCVRVYTPVGKAEQGKFA--- 187
Cdd:cd09602  148 TAPADWTVISNGPETST---EEAGGRKRWRFAETPPLSTYLFAFVAGPYHRVE-DEHDGIPLGLYCRESLAEYERDAdei 223
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 188 LEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNScsSSRQWVALVVGHELAHQWFGN 267
Cdd:cd09602  224 FEVTKQGLDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFREEPTR--AQRLRRANTILHEMAHMWFGD 301
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 268 LVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYSKG 347
Cdd:cd09602  302 LVTMKWWDDLWLNESFADFMAAKALAEATPFTDAWLTFLLRRKPWAYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKG 381
                        330       340       350       360       370
                 ....*....|....*....|....*....|....*....|....*....|....*....
gi 193788461 348 ASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAvmntWTKQ 406
Cdd:cd09602  382 ASVLKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAALDEASGRDLSA----WADA 436
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
31-389 1.97e-101

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 318.23  E-value: 1.97e-101
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  31 EDEKVTLSFPSTlQTGTGTLKIDFVGELNDKMKGFYRSKYttpSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDISL 110
Cdd:cd09595   61 DGEKLTIPGPKP-PGQTFTVRISFEAKPSKNLLGWLWEQT---AGKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTI 136
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 111 VVPKDRVALSNMNVIDRKPYPDDENlvEVKFARTPVMSTYLVAFVVG--EYDFVETRSKDGVCVRVYTPVGKAEQGKFAL 188
Cdd:cd09595  137 TTPKKDLLASNGALVGEETGANGRK--TYRFEDTPPIPTYLVAVVVGdlEFKYVTVKSQPRVGLSVYSEPLQVDQAQYAF 214
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 189 EVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDpKNSCSSSRQwVALVVGHELAHQWFGNL 268
Cdd:cd09595  215 DATRAALAWFEDYFGGPYPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRS-KVTDTGARS-IENVIAHELAHQWFGNL 292
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 269 VTMEWWTHLWLNEGFASWIEYLCVDHCFPEyDIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYSKGA 348
Cdd:cd09595  293 VTMRWWNDLWLNEGFAVYYENRIMDATFGT-SSRHLDQLSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGA 371
                        330       340       350       360
                 ....*....|....*....|....*....|....*....|.
gi 193788461 349 SVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLE 389
Cdd:cd09595  372 LVLRMLEELVGEEAFDKGVQAYFNRHKFKNATTDDFIDALE 412
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
484-756 3.19e-89

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 283.01  E-value: 3.19e-89
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  484 WVKLNLGTVGFYRTQYSSAMLESLLPGIRDLSLPPVDRLGLQNDLFSLSRAGIISTVEVLKVMEAFVNEPNYTVWSDLSC 563
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  564 NLGILSTLLSHTDFYEEIQEFVKDVFSPIGERLGWDPKPGEGHLDALLRGLVLGKLGKAGHKATLEEAHRRFKDHVEGKQ 643
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  644 ILSADLRSPVYLTVLKHGDGTTLDIMLKLHKQADMQEEKNRIERVLGATLLPDLIQKVLTFAL-SEEVRPQDTVSVIGGV 722
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270
                  ....*....|....*....|....*....|....
gi 193788461  723 AGgSKHGRKAAWKFIKDNWEELYNRYQGGFLISY 756
Cdd:pfam11838 241 AS-NPAGRDLAWDFVKENWDALVKRLGGGSSLGR 273
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
42-424 5.89e-81

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 275.90  E-value: 5.89e-81
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   42 TLQTGTGTLKIDFVGELNDKMKGFYRskYTTPS-GEVrYAaVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALS 120
Cdd:TIGR02412  84 GLLTGENTLRVEATRAYTNTGEGLHR--FVDPVdGEV-YL-YTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVIS 159
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  121 NMNVIDRKPYPDDENLvevKFARTPVMSTYLVAFVVGEYDFVETRSkDGVCVRVYTPVGKAEQ--GKFALEVAAKTLPFY 198
Cdd:TIGR02412 160 NSRETDVTPEPADRRW---EFPETPKLSTYLTAVAAGPYHSVQDES-RSYPLGIYARRSLAQYldADAIFTITRQGLAFF 235
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  199 KDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNScsSSRQWVALVVGHELAHQWFGNLVTMEWWTHLW 278
Cdd:TIGR02412 236 HRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEATR--AEKENRAGVILHEMAHMWFGDLVTMRWWNDLW 313
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  279 LNEGFASWIEYLCVDHCfPEY-DIWTQFVSADYTRAQELDALDNSHPIEVSVGHPSEVDEIFDAISYSKGASVIRMLHDY 357
Cdd:TIGR02412 314 LNESFAEYMGTLASAEA-TEYtDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAW 392
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 193788461  358 IGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTWTKQMGFPLIYVEAEqVEDDRL 424
Cdd:TIGR02412 393 VGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEIT-TDGGVV 458
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
28-403 1.10e-73

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 245.19  E-value: 1.10e-73
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  28 YQNEDEKVTLSFPSTLQTG-TGTLKIDFVGElNDKMKGFYRSKYTTPSGevRYAAVTQFEATDARRAFPCWDEPAIKATF 106
Cdd:cd09603   58 FTHDGDKLVITLPRPLAAGeTFTVTVRYSGK-PRPAGYPPGDGGGWEEG--DDGVWTAGQPEGASTWFPCNDHPDDKATY 134
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 107 DISLVVPKDRVALSNMNVIDRKPYPDdeNLVEVKFA-RTPvMSTYLVAFVVGEYDFVETRSKDGVCVRVYTPVGKAEQGK 185
Cdd:cd09603  135 DITVTVPAGLTVVSNGRLVSTTTNGG--GTTTWHWKmDYP-IATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAK 211
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 186 FALEVAAKTLPFYKDYFnVPYPLPKIDLIAIADFAaGAMENWGLVTYRETALLIDPKnscsssrqWVALVVgHELAHQWF 265
Cdd:cd09603  212 ASFARTPEMLDFFEELF-GPYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRG--------SERLIA-HELAHQWF 280
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 266 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDiwtqfvsADYTRAQELDALDNSHPIevsVGHPSEVDEIFDAISYS 345
Cdd:cd09603  281 GDSVTCADWADIWLNEGFATYAEWLWSEHKGGADA-------YRAYLAGQRQDYLNADPG---PGRPPDPDDLFDRDVYQ 350
                        330       340       350       360       370
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 193788461 346 KGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTW 403
Cdd:cd09603  351 KGALVLHMLRNLLGDEAFFAALRAYLARYAHGNVTTEDFIAAAEEVSGRDLTWFFDQW 408
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
1-151 8.44e-60

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 199.88  E-value: 8.44e-60
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461    1 MNCADIDIITASY-APEGDEEIHATGFNYQNEDEKVTLSFPSTL-QTGTGTLKIDFVGELNDKMKGFYRSKYTTpSGEVR 78
Cdd:pfam17900  37 LHASDLTIRSISLsDEVTSDGVPADFTEDQKDGEKLTIVLPETLnQTGPYTLEIEYSGELNDSMTGFYRSTYTD-NGEKK 115
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 193788461   79 YAAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALSNMNVIDRKPYPDdeNLVEVKFARTPVMSTYL 151
Cdd:pfam17900 116 VLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSNMPVIASEPLEN--GWVITTFEQTPKMSTYL 186
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
28-404 1.90e-42

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 159.99  E-value: 1.90e-42
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  28 YQNEDEKVTLSFPS---TLQTGTgtlKIDfvGELNDKMKGFYRSKYTTpsgevryaaVTQFEATDARRA--FPcwDEPAI 102
Cdd:cd09600   67 YTLDEEGLTIKNVPdrfVLEIEV---RIN--PAANTSLEGLYKSGGIL---------CTQCEAEGFRRItyFP--DRPDV 130
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 103 KATFDISLVVPKDR--VALSNMNVIDRKPYPDdeNLVEVKFARTPVMSTYLVAFVVGEYDFVE----TRSKDGVCVRVYT 176
Cdd:cd09600  131 MSKFTVTIEADKEKypVLLSNGNLIEEGELPN--GRHFAVWEDPFPKPSYLFALVAGDLGSVEdtftTKSGRKVKLRIYV 208
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 177 PVGKAEQGKFALEVAAKTLPFYKDYFNVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCSSSRQWVALVV 256
Cdd:cd09600  209 EPGNEDKCHHAMESLKKAMKWDEERFGLEYDLDLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVI 288
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 257 GHELAHQWFGNLVTMEWWTHLWLNEGfaswieyLCV--DHCFPE----------YDI----WTQFVSadytraqelDALD 320
Cdd:cd09600  289 AHEYFHNWTGNRVTCRDWFQLSLKEG-------LTVfrDQEFSAdmnsravkriEDVrrlrSAQFPE---------DAGP 352
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 321 NSHPIEvsvghPSEVDEI---FDAISYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIA 397
Cdd:cd09600  353 MAHPIR-----PDSYIEInnfYTVTVYEKGAEVIRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLS 427

                 ....*..
gi 193788461 398 AVMNTWT 404
Cdd:cd09600  428 QFKRWYS 434
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
104-403 1.56e-34

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 137.02  E-value: 1.56e-34
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 104 ATFDISLVVPKD-RVALSNmNVIDRKPYPDDENLVEVK------FArtpvmstylvaFVVGEyDF-VETRSKDGVCVRVY 175
Cdd:cd09604  161 GDYDVTITVPKNyVVAATG-ELQNPEEVLDGTKTWHFKaenvrdFA-----------WAASP-DFvVDAATVDGVTVNVY 227
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 176 TPVGKAEQGKFALEVAAKTLPFYKDYFnVPYPLPKIDLIAiADFAAGAMENWGLVTyretallIDPKNScsSSRQWVALV 255
Cdd:cd09604  228 YLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGMEYPGLVF-------IGSRLY--DPKRSLEGV 296
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 256 VGHELAHQWF----GNLVTMEwwthLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRAQEldalDNSHPIEVSVGH 331
Cdd:cd09604  297 VVHEIAHQWFygivGNDERRE----PWLDEGLATYAESLYLEEKYGKEAADELLGRRYYRAYAR----GPGGPINLPLDT 368
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 193788461 332 PSEVDEIFDAIsYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATEDLWESLENASGRPIAAVMNTW 403
Cdd:cd09604  369 FPDGSYYSNAV-YSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVSGKDLDWFFRGW 439
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
83-390 9.51e-25

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 107.93  E-value: 9.51e-25
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  83 TQFEATDARRAFPCWDEPAIKATFDISLVVPKDRVALsnMNVIdRKPYPDDENLVEVKFaRTPV-MSTYLVAFVVGEYDF 161
Cdd:cd09599  129 TQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTAL--MSAL-RTGEKEEAGTGTYTF-EQPVpIPSYLIAIAVGDLES 204
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 162 VET--RSkdgvcvRVYTPVGKAEQGK--FA-----LEVAAKTLPfykdyfnvPYPLPKID-LIAIADFAAGAMENWGLVT 231
Cdd:cd09599  205 REIgpRS------GVWAEPSVVDAAAeeFAdtekfLKAAEKLYG--------PYVWGRYDlLVLPPSFPYGGMENPCLTF 270
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 232 YreTALLIdpknscSSSRQWVALVVgHELAHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCF-PEYdiwTQFVSA-- 308
Cdd:cd09599  271 A--TPTLI------AGDRSLVDVIA-HEIAHSWSGNLVTNANWEHFWLNEGFTVYLERRILERLYgEEY---RQFEAIlg 338
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 309 DYTRAQELDALDNSHP-----IEVSVGHPsevDEIFDAISYSKGASVIRMLHDYIGDKDFKKGMNMYLTKFQQKNAATED 383
Cdd:cd09599  339 WKDLQESIKEFGEDPPytllvPDLKGVDP---DDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTED 415

                 ....*..
gi 193788461 384 LWESLEN 390
Cdd:cd09599  416 FKDFLLE 422
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
34-410 6.45e-22

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 100.62  E-value: 6.45e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461   34 KVTLSFPSTLQTGTG-TLKIDFvgELNDKMKGF-YRSKYTTPSGEVRYAaVTQFEATDARRAFPCWDEPAIKATFDISLV 111
Cdd:TIGR02411  80 PLTISLPIATSKNDEfVLNISF--STTPKCTALqWLNPEQTSGKKHPYL-FSQCQAIHARSLFPCQDTPSVKSTYTAEVE 156
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  112 VPkdRVALsnMNVIDRKPYPDDENlveVKFARTPV-MSTYLVAFVVGEYDF--VETRSKdgvcvrVYT-PVG-KAEQGKF 186
Cdd:TIGR02411 157 SP--LPVL--MSGIRDGETSNDPG---KYLFKQKVpIPAYLIAIASGDLASapIGPRST------VYSePEQlEKCQYEF 223
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  187 ALEV-----AAKTLPFykdyfnvPYPLPKIDLIAIAD-FAAGAMENWGLvTYRETALLidpknscSSSRQWVAlVVGHEL 260
Cdd:TIGR02411 224 ENDTekfikTAEDLIF-------PYEWGQYDLLVLPPsFPYGGMENPNL-TFATPTLI-------AGDRSNVD-VIAHEL 287
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  261 AHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYdiwTQFVSA--DYTRAQE-LDALDNSHPIEVSVGHPSEV-- 335
Cdd:TIGR02411 288 AHSWSGNLVTNCSWEHFWLNEGWTVYLERRIIGRLYGEK---TRHFSAliGWGDLQEsVKTLGETPEFTKLVVDLKDNdp 364
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  336 DEIFDAISYSKGASVIRMLHDYIGD-KDFKKGMNMYLTKFQQKNAATEDLWESL-ENASGRPIAAVMN-----TWTKQMG 408
Cdd:TIGR02411 365 DDAFSSVPYEKGFNFLFYLEQLLGGpAEFDPFLRHYFKKFAYKSLDTYQFKDALyEYFKDKKKVDKLDavdweTWLYSPG 444

                  ..
gi 193788461  409 FP 410
Cdd:TIGR02411 445 MP 446
pepN PRK14015
aminopeptidase N; Provisional
64-434 2.67e-20

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 96.35  E-value: 2.67e-20
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  64 GFYRSkyttpSGevryAAVTQFEATDARRAFPCWDEPAIKATFDISLVVPKDR--VALSNMNVIDRKPYPDDEnlvevKF 141
Cdd:PRK14015 113 GLYRS-----GG----MFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKypVLLSNGNLVESGELPDGR-----HW 178
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 142 AR----TPVMStYLVAFVVGEYDFVE----TRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNVPYplpkiDL 213
Cdd:PRK14015 179 ATwedpFPKPS-YLFALVAGDLDVLEdtftTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY-----DL 252
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 214 -----IAIADFAAGAMENWGLVTYRETALLIDPKNSCSSSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGfaswie 288
Cdd:PRK14015 253 difmiVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEG------ 326
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 289 yLCV--DHCFpeydiwtqfvSAD-------------YTRAQEL--DALDNSHPIEvsvghPSEVDEI---FDAISYSKGA 348
Cdd:PRK14015 327 -LTVfrDQEF----------SADlgsravkriedvrVLRAAQFaeDAGPMAHPVR-----PDSYIEInnfYTATVYEKGA 390
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 349 SVIRMLHDYIGDKDFKKGMNMYLTKF--QqknAAT-EDLWESLENASGRPIAAVMNtWTKQMGFPLIYVEAEQVEDDRLL 425
Cdd:PRK14015 391 EVIRMLHTLLGEEGFRKGMDLYFERHdgQ---AVTcEDFVAAMEDASGRDLSQFRR-WYSQAGTPRVTVSDEYDAAAGTY 466

                 ....*....
gi 193788461 426 RLSQKKFCA 434
Cdd:PRK14015 467 TLTLSQSTP 475
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
94-376 9.09e-09

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 58.78  E-value: 9.09e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461  94 FPCWDEPAIKATFDISLVVPK-----DRVALSNMNVIDRKPYPDDE------------NLVEVKFarTP------VMSTY 150
Cdd:cd09839  180 FPCVDSLWERCTWELEITVPRtlgdaGRPPLAGSKEDEDDDDLTEEdkelemvvvcsgDLVEQVV--HPedpskkTFSFS 257
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 151 L--------VAFVVG-----------EYDFVETRSKDGVCVRVYTPVGKAEQGKFALEVAAKTLPFYKDYFNvPYPLP-- 209
Cdd:cd09839  258 LsnptsaqhIGFAVGpfeivplpefrESEEDDKLGSSAVEVTGFCLPGRLEELRNTCSFLHKAMDFFEEEYG-SYPFSsy 336
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 210 KI----DLIA-IADFAAGAMENwglvtyreTALL-----IDPknsCSSSRQwvALVvgHELAHQWFGNLVTMEWWTHLWL 279
Cdd:cd09839  337 KQvfvdDLPEdVSSFASLSICS--------SRLLyppdiIDQ---AYETRR--KLA--HALASQWFGINIIPKTWSDTWL 401
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 280 NEGFASWIEYLCVDHCF--PEYDIWTQfvsadyTRAQELDALDNSHPievSVGHPSEV----DEIFDAISYsKGASVIRM 353
Cdd:cd09839  402 VIGIAGYMTGLFLKKLFgnNEYRFRIK------KDADRVCELDIGRP---PLAQPGFIlpldPSELEFMAL-KAPLVLFI 471
                        330       340
                 ....*....|....*....|....
gi 193788461 354 LHDYIGDKDFKKGMNMYLTK-FQQ 376
Cdd:cd09839  472 LDRRLTKTGGSFGLSRVLPKiFLQ 495
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
189-290 4.84e-07

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 48.63  E-value: 4.84e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 193788461 189 EVAAKTLPFYKDYFNVPYPLPKIDLI--------AIADFAAGAMENWGLVTY------RETALLIDpknscsssrqwval 254
Cdd:cd09594    2 SYAHETYKYYEELLGRTSFRYPVSPIysllvypaYVEVNAYNAMWIPSTNIFygagilDTLSGTID-------------- 67
                         90       100       110
                 ....*....|....*....|....*....|....*..
gi 193788461 255 VVGHELAHQWFGNLVTMEW-WTHLWLNEGFASWIEYL 290
Cdd:cd09594   68 VLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGL 104
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH